PharmaResearch Co (XKRX:214450) Accounts Payable & Accrued Expense : ₩49,398 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is PharmaResearch Co Accounts Payable & Accrued Expense?

PharmaResearch Co's quarterly accounts payable & accrued expense declined from Sep. 2023 (₩30,328 Mil) to Dec. 2023 (₩28,972 Mil) but then increased from Dec. 2023 (₩28,972 Mil) to Mar. 2024 (₩49,398 Mil).

PharmaResearch Co's annual accounts payable & accrued expense increased from Dec. 2021 (₩23,241 Mil) to Dec. 2022 (₩29,550 Mil) but then declined from Dec. 2022 (₩29,550 Mil) to Dec. 2023 (₩28,972 Mil).

PharmaResearch Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for PharmaResearch Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaResearch Co Accounts Payable & Accrued Expense Chart

PharmaResearch Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

12,901.70

13,617.16

23,241.36

29,550.01

28,971.69

PharmaResearch Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															30,120.80	27,075.02	30,327.65	28,971.69	49,398.38

PharmaResearch Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

PharmaResearch Co (XKRX:214450) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaResearch Co Ltd (XKRX:214450) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

74 Pangyo-ro 255beon-gil, Bundang-gu, Gyeonggi-do, Seongnam, KOR, 463-400

Website

http://www.pr-products.co.kr

PharmaResearch Co Ltd formerly Pharma Research Products Co Ltd is a bio pharmaceutical firm which realizes a new treatment paradigm for regenerative medicine. Its products include Rejuran, Rejuvenex, and Re-An eye drops. It also provides medical devices, cosme ceuticals, and dietary supplements.

PharmaResearch Co (XKRX:214450) Headlines

No Headlines